BiotechnologyLeap Therapeutics to Host Virtual R&D Day on July 12, 2022

Leap Therapeutics, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will host a virtual R&D Day on July 12, 2022 at 12:00 pm ET. Leap’s executive management team will be joined by distinguished key opinion leaders to share emerging data for the Company’s lead clinical candidate, DKN-01, a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, and provide updates to its clinical development strategy.

A live webcast of the event may be accessed on the Investors page of the company’s website at https://investors.leaptx.com/, where a replay of the event will also be available for a limited time.